Learning from a decade of progress in amyloidosis

The Lancet · Published 2026-07-30 · DOI 10.1016/s0140-6736(26)01548-5

Authors (1)

The Lancet

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Citation

Lancet, T. (2026). Learning from a decade of progress in amyloidosis. The Lancet. https://doi.org/10.1016/s0140-6736(26)01548-5

Related articles

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial · The Lancet · 2026 · Same journal
David Rosner · The Lancet · 2026 · Same journal
Rethinking anticoagulation intensity during extracorporeal membrane oxygenation · The Lancet · 2026 · Same journal
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial · The Lancet · 2026 · Same journal
Embracing neurodiversity in medicine: insights from the history of psychiatry · The Lancet · 2026 · Same journal
Cambodia reaches HIV milestone · The Lancet · 2026 · Same journal
Department of Error · The Lancet · 2026 · Same journal
PUSH trial limits: why fluids still matter · The Lancet · 2026 · Same journal
Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies · The Lancet · 2026 · Same journal
Judith Rapoport · The Lancet · 2026 · Same journal